Glut-1 expression in breast cancer
Author(s) -
Oğuzhan Okçu,
Bayram Şen,
Çiğdem Öztürk,
Gülname Fındık Güvendi,
Recep Bedir
Publication year - 2021
Publication title -
turkish journal of pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.305
H-Index - 14
eISSN - 1309-5730
pISSN - 1018-5615
DOI - 10.5146/tjpath.2021.01557
Subject(s) - breast cancer , progesterone receptor , medicine , oncology , nottingham prognostic index , estrogen receptor , glut1 , immunohistochemistry , univariate analysis , pathological , neoadjuvant therapy , triple negative breast cancer , cancer , glucose transporter , multivariate analysis , insulin
Numerous studies have been conducted to predict the prognosis of breast cancers. The effect of glucose transporter protein 1 (GLUT-1), the main carrier protein responsible for glucose transport, was investigated in breast cancer patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom